BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 20166088)

  • 21. SAHIT Investigators--on the outcome of some subarachnoid hemorrhage clinical trials.
    Macdonald RL; Jaja B; Cusimano MD; Etminan N; Hanggi D; Hasan D; Ilodigwe D; Lantigua H; Le Roux P; Lo B; Louffat-Olivares A; Mayer S; Molyneux A; Quinn A; Schweizer TA; Schenk T; Spears J; Todd M; Torner J; Vergouwen MD; Wong GK; Singh J;
    Transl Stroke Res; 2013 Jun; 4(3):286-96. PubMed ID: 24323299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium antagonists for aneurysmal subarachnoid haemorrhage.
    Feigin VL; Rinkel GJ; Algra A; Vermeulen M; van Gijn J
    Cochrane Database Syst Rev; 2000; (2):CD000277. PubMed ID: 10796337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study.
    Haley EC; Kassell NF; Alves WM; Weir BK; Hansen CA
    J Neurosurg; 1995 May; 82(5):786-90. PubMed ID: 7714603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Cilostazol on Cerebral Vasospasm and Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Matsuda N; Naraoka M; Ohkuma H; Shimamura N; Ito K; Asano K; Hasegawa S; Takemura A
    Cerebrovasc Dis; 2016; 42(1-2):97-105. PubMed ID: 27070952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with the development of vasospasm after planned surgical treatment of aneurysmal subarachnoid hemorrhage.
    Macdonald RL; Rosengart A; Huo D; Karrison T
    J Neurosurg; 2003 Oct; 99(4):644-52. PubMed ID: 14567598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnesium sulfate in combination with nimodipine for the treatment of subarachnoid hemorrhage: a randomized controlled clinical study.
    Zhang C; Zhao S; Zang Y; Zhao W; Song Q; Feng S; Hu L; Gu F
    Neurol Res; 2018 Apr; 40(4):283-291. PubMed ID: 29540123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metaanalysis of trials of tirilazad mesylate in aneurysmal SAH.
    Dorsch NW; Kassell NF; Sinkula MS
    Acta Neurochir Suppl; 2001; 77():233-5. PubMed ID: 11563295
    [No Abstract]   [Full Text] [Related]  

  • 28. Circulatory volume expansion therapy for aneurysmal subarachnoid haemorrhage.
    Rinkel GJ; Feigin VL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2004 Oct; 2004(4):CD000483. PubMed ID: 15494997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage.
    Roos YB; Rinkel GJ; Vermeulen M; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2000; (2):CD001245. PubMed ID: 10796425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of cerebral infarction in patients with aneurysmal subarachnoid hemorrhage.
    Ferguson S; Macdonald RL
    Neurosurgery; 2007 Apr; 60(4):658-67; discussion 667. PubMed ID: 17415202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnesium sulphate in the management of patients with aneurysmal subarachnoid haemorrhage: a meta-analysis of prospective controlled trials.
    Ma L; Liu WG; Zhang JM; Chen G; Fan J; Sheng HS
    Brain Inj; 2010; 24(5):730-5. PubMed ID: 20334471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraoperative mild hypothermia for postoperative neurological deficits in intracranial aneurysm patients.
    Li LR; You C; Chaudhary B
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008445. PubMed ID: 22336843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders.
    Di Mascio R; Marchioli R; Tognoni G
    Clin Trials Metaanal; 1994 Apr; 29(1):57-79. PubMed ID: 10150186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dan Shen agents for acute ischaemic stroke.
    Wu B; Liu M; Zhang S
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004295. PubMed ID: 15495099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial.
    Pickard JD; Murray GD; Illingworth R; Shaw MD; Teasdale GM; Foy PM; Humphrey PR; Lang DA; Nelson R; Richards P
    BMJ; 1989 Mar; 298(6674):636-42. PubMed ID: 2496789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect and management of delayed vasospasm after aneurysmal subarachnoid hemorrhage.
    Dorsch NW
    Neurol Med Chir (Tokyo); 1998; 38 Suppl():156-60. PubMed ID: 10234999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of Ginkgo biloba extract in acute ischemic stroke.
    Liu J
    Explore (NY); 2006 May; 2(3):262-3. PubMed ID: 16781654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury.
    Marshall LF; Maas AI; Marshall SB; Bricolo A; Fearnside M; Iannotti F; Klauber MR; Lagarrigue J; Lobato R; Persson L; Pickard JD; Piek J; Servadei F; Wellis GN; Morris GF; Means ED; Musch B
    J Neurosurg; 1998 Oct; 89(4):519-25. PubMed ID: 9761043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Indications for steroid and tirilazad treatment in patients with subarachnoid hemorrhage].
    Tommasino C; Picozzi P
    Minerva Anestesiol; 1998 May; 64(5):225-7. PubMed ID: 9773664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.